• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算设计的白细胞介素-2 超家族。

Interleukin-2 superkines by computational design.

机构信息

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.

HHMI, Stanford University School of Medicine, Stanford, CA 94305.

出版信息

Proc Natl Acad Sci U S A. 2022 Mar 22;119(12):e2117401119. doi: 10.1073/pnas.2117401119. Epub 2022 Mar 16.

DOI:10.1073/pnas.2117401119
PMID:35294290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8944926/
Abstract

Affinity maturation of protein–protein interactions is an important approach in the development of therapeutic proteins such as cytokines. Typical experimental strategies involve targeting the cytokine-receptor interface with combinatorial libraries and then selecting for higher-affinity variants. Mutations to the binding scaffold are usually not considered main drivers for improved affinity. Here we demonstrate that computational design can provide affinity-enhanced variants of interleukin-2 (IL-2) “out of the box” without any requirement for interface engineering. Using a strategy of global IL-2 structural stabilization targeting metastable regions of the three-dimensional structure, rather than the receptor binding interfaces, we computationally designed thermostable IL-2 variants with up to 40-fold higher affinity for IL-2Rβ without any library-based optimization. These IL-2 analogs exhibited CD25-independent activities on T and natural killer (NK) cells both in vitro and in vivo, mimicking the properties of the IL-2 superkine “super-2” that was engineered through yeast surface display [A. M. Levin et al., Nature, 484, 529–533 (2012)]. Structure-guided stabilization of cytokines is a powerful approach to affinity maturation with applications to many cytokine and protein–protein interactions.

摘要

蛋白质-蛋白质相互作用的亲和力成熟是开发治疗性蛋白(如细胞因子)的重要方法。典型的实验策略包括使用组合文库靶向细胞因子-受体界面,然后选择具有更高亲和力的变体。通常不考虑结合支架的突变是提高亲和力的主要驱动力。在这里,我们证明计算设计可以在不进行任何界面工程的情况下,“从零开始”提供具有增强亲和力的白细胞介素-2(IL-2)变体。我们采用了一种针对三维结构的亚稳定区域而不是受体结合界面的全局 IL-2 结构稳定化策略,通过计算设计出了具有高达 40 倍更高亲和力的热稳定 IL-2 变体,用于 IL-2Rβ,而无需任何基于文库的优化。这些 IL-2 类似物在体外和体内均表现出对 T 和自然杀伤(NK)细胞的 CD25 非依赖性活性,模拟了通过酵母表面展示工程化的 IL-2 超家族“超级 2”的特性[A. M. Levin 等人,《自然》,484,529-533(2012)]。细胞因子的结构导向稳定是一种强大的亲和力成熟方法,可应用于许多细胞因子和蛋白质-蛋白质相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/4596787bd821/pnas.2117401119fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/a2b8c3af46e3/pnas.2117401119fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/64d852815352/pnas.2117401119fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/124855ecf00e/pnas.2117401119fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/4596787bd821/pnas.2117401119fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/a2b8c3af46e3/pnas.2117401119fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/64d852815352/pnas.2117401119fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/124855ecf00e/pnas.2117401119fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/8944926/4596787bd821/pnas.2117401119fig04.jpg

相似文献

1
Interleukin-2 superkines by computational design.通过计算设计的白细胞介素-2 超家族。
Proc Natl Acad Sci U S A. 2022 Mar 22;119(12):e2117401119. doi: 10.1073/pnas.2117401119. Epub 2022 Mar 16.
2
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.利用天然构象转变来设计白细胞介素-2“超级激动剂”。
Nature. 2012 Mar 25;484(7395):529-33. doi: 10.1038/nature10975.
3
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.ALKs 4230:一种新型工程化的 IL-2 融合蛋白,具有改善的细胞选择性特征,可用于癌症免疫治疗。
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2020-000673.
4
Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles.在β链受体界面处对噬菌体展示的白细胞介素-2进行分子重塑,以获得具有改善开发特性的强效超激动剂。
Commun Biol. 2023 Aug 9;6(1):828. doi: 10.1038/s42003-023-05188-0.
5
Protein Engineering by Combined Computational and In Vitro Evolution Approaches.通过组合计算和体外进化方法进行蛋白质工程。
Trends Biochem Sci. 2016 May;41(5):421-433. doi: 10.1016/j.tibs.2016.03.002. Epub 2016 Apr 6.
6
Regulating IL-2 immune signaling function via a core allosteric structural network.通过核心变构结构网络调节白细胞介素-2免疫信号功能。
bioRxiv. 2024 Oct 8:2024.10.07.617024. doi: 10.1101/2024.10.07.617024.
7
Identifying Residues that Determine SCF Molecular-Level Interactions through a Combination of Experimental and In silico Analyses.通过实验分析与计算机模拟相结合的方法确定决定SCF分子水平相互作用的残基
J Mol Biol. 2017 Jan 6;429(1):97-114. doi: 10.1016/j.jmb.2016.11.018. Epub 2016 Nov 25.
8
Affinity maturation of a computationally designed binding protein affords a functional but disordered polypeptide.计算设计的结合蛋白的亲和成熟赋予了一种功能性但无序的多肽。
J Struct Biol. 2014 Feb;185(2):168-77. doi: 10.1016/j.jsb.2013.03.008. Epub 2013 Mar 26.
9
Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.利用酵母表面展示组合Fc文库筛选技术构建免疫球蛋白Fc异源二聚体
PLoS One. 2015 Dec 16;10(12):e0145349. doi: 10.1371/journal.pone.0145349. eCollection 2015.
10
Engineering protein therapeutics: predictive performances of a structure-based virtual affinity maturation protocol.工程蛋白治疗学:基于结构的虚拟亲和力成熟方案的预测性能。
J Chem Inf Model. 2012 Aug 27;52(8):2204-14. doi: 10.1021/ci3001474. Epub 2012 Jul 24.

引用本文的文献

1
Selectivity of bovine interleukin-2 mutein stimulation on bovine peripheral blood mononuclear cells.牛白细胞介素-2突变体对牛外周血单个核细胞刺激的选择性
J Vet Med Sci. 2025 Jul 7;87(7):781-790. doi: 10.1292/jvms.24-0470. Epub 2025 May 30.
2
Directed disruption of IL2 aggregation and receptor binding sites produces designer biologics with enhanced specificity and improved production capacity.定向破坏白细胞介素-2的聚集和受体结合位点可产生具有更高特异性和更强生产能力的定制生物制剂。
Comput Struct Biotechnol J. 2025 Mar 4;27:1112-1123. doi: 10.1016/j.csbj.2025.03.002. eCollection 2025.
3
Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles.

本文引用的文献

1
Recent advances in de novo protein design: Principles, methods, and applications.从头设计蛋白质的最新进展:原理、方法和应用。
J Biol Chem. 2021 Jan-Jun;296:100558. doi: 10.1016/j.jbc.2021.100558. Epub 2021 Mar 18.
2
Bottom-up de novo design of functional proteins with complex structural features.从头设计具有复杂结构特征的功能性蛋白质。
Nat Chem Biol. 2021 Apr;17(4):492-500. doi: 10.1038/s41589-020-00699-x. Epub 2021 Jan 4.
3
Engineering IL-2 to Give New Life to T Cell Immunotherapy.工程化 IL-2 为 T 细胞免疫疗法注入新活力。
利用工程化细胞外囊泡将免疫调节剂直接递送至肿瘤浸润淋巴细胞。
J Extracell Vesicles. 2025 Apr;14(4):e70035. doi: 10.1002/jev2.70035.
4
Presetting CAR-T cells during ex vivo biomanufacturing.在体外生物制造过程中预设嵌合抗原受体T细胞(CAR-T细胞)
Mol Ther. 2025 Apr 2;33(4):1380-1406. doi: 10.1016/j.ymthe.2025.02.031. Epub 2025 Feb 22.
5
Regulating IL-2 Immune Signaling Function Via A Core Allosteric Structural Network.通过核心变构结构网络调节白细胞介素-2免疫信号功能
J Mol Biol. 2025 Jan 15;437(2):168892. doi: 10.1016/j.jmb.2024.168892. Epub 2024 Dec 9.
6
Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.白细胞介素-2 的分子工程改造增强在自身免疫性疾病中的治疗活性。
BioDrugs. 2024 Mar;38(2):227-248. doi: 10.1007/s40259-023-00635-0. Epub 2023 Nov 24.
7
De Novo Design of a Highly Stable Ovoid TIM Barrel: Unlocking Pocket Shape towards Functional Design.高度稳定的卵形TIM桶的从头设计:解锁口袋形状以实现功能设计。
Biodes Res. 2022 Oct 10;2022:9842315. doi: 10.34133/2022/9842315. eCollection 2022.
8
Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles.在β链受体界面处对噬菌体展示的白细胞介素-2进行分子重塑,以获得具有改善开发特性的强效超激动剂。
Commun Biol. 2023 Aug 9;6(1):828. doi: 10.1038/s42003-023-05188-0.
9
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies.重新点燃癌症治疗的希望:IL-2 和 IL-2R 靶向策略的前景与挑战。
Mol Cancer. 2023 Jul 29;22(1):121. doi: 10.1186/s12943-023-01826-7.
10
Advances in engineering and delivery strategies for cytokine immunotherapy.细胞因子免疫疗法的工程和输送策略的进展。
Expert Opin Drug Deliv. 2023 May;20(5):579-595. doi: 10.1080/17425247.2023.2208344. Epub 2023 May 3.
Annu Rev Med. 2021 Jan 27;72:281-311. doi: 10.1146/annurev-med-073118-011031. Epub 2020 Nov 6.
4
An Adaptive Control Scheme for Interleukin-2 Therapy.白细胞介素-2治疗的一种自适应控制方案
iScience. 2020 Oct 12;23(11):101663. doi: 10.1016/j.isci.2020.101663. eCollection 2020 Nov 20.
5
Macromolecular modeling and design in Rosetta: recent methods and frameworks.罗塞塔中的大分子建模和设计:最新方法和框架。
Nat Methods. 2020 Jul;17(7):665-680. doi: 10.1038/s41592-020-0848-2. Epub 2020 Jun 1.
6
De novo protein design enables the precise induction of RSV-neutralizing antibodies.从头设计蛋白质可精确诱导 RSV 中和抗体。
Science. 2020 May 15;368(6492). doi: 10.1126/science.aay5051.
7
Interleukin-2 druggability is modulated by global conformational transitions controlled by a helical capping switch.白细胞介素-2 的成药性受螺旋帽开关控制的全局构象转变调节。
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7183-7192. doi: 10.1073/pnas.2000419117. Epub 2020 Mar 17.
8
protein design, a retrospective.蛋白质设计:回顾
Q Rev Biophys. 2020 Feb 11;53:e3. doi: 10.1017/S0033583519000131.
9
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity.细胞因子受体运输的动力学决定了信号转导和功能选择性。
Elife. 2019 Nov 27;8:e49314. doi: 10.7554/eLife.49314.
10
De novo design of potent and selective mimics of IL-2 and IL-15.从头设计强效且高选择性的 IL-2 和 IL-15 模拟物。
Nature. 2019 Jan;565(7738):186-191. doi: 10.1038/s41586-018-0830-7. Epub 2019 Jan 9.